Not all B12 supplementation methods are created equal
It is important to recognize that, while BPC-157 offers unique benefits in laboratory settingssuch as enhanced cell migration, improved tissue repair, and inflammation controlit is not approved for human consumption or as a treatment for any disease
P2Y 2 receptor agonists, denufosol (OLIYNYK et al., 2010), were promising for their ability to activate alternative chloride secretion pathways, but both of these agonists have not been pursued further due to not meeting primary study goals of improving FEV 1 (Ratjen et al., 2012) and having a narrow effective concentration range, respectively (OLIYNYK et al., 2010)
BPC-157 acts on distinct signaling pathways
HGF/c-Met receptor activation: Dihexa binds to and activates the hepatocyte growth factor (HGF) and c-Met receptor system, a powerful signaling pathway involved in cell growth, repair, and neurogenesis
(FDA Access Data) Tier 2 Human evidence exists, but not necessarily for your goal CJC-1295 effects on GH/IGF-1 in healthy adults (mechanistic human data) (PubMed) Ipamorelin mechanistic clinical literature (PubMed) Tier 3 Mostly preclinical / limited human BPC-157 (preclinical-heavy